Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04616534
Title Testing the Addition of an Anti-cancer Drug, BAY 1895344 ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)

peritoneum cancer

fallopian tube cancer

Advanced Solid Tumor

ovarian cancer

pancreatic adenocarcinoma

pancreatic cancer


BAY1895344 + Gemcitabine

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.